Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.
Favier J, Igaz P, Burnichon N, Amar L, Libé R, Badoual C, Tissier F, Bertherat J, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP.
Favier J, et al.
Endocr Pathol. 2012 Mar;23(1):34-42. doi: 10.1007/s12022-011-9189-0.
Endocr Pathol. 2012.
PMID: 22183643